The Journal of Immunology, Vol 156, Issue 3 948-956, Copyright © 1996 by American Association of Immunologists

ARTICLES

Isolation and characterization of cell lines with genetically distinct mutations downstream of protein kinase C that result in defective activation-dependent regulation of T cell integrin function

JL Mobley, E Ennis and Y Shimizu
Department of Laboratory Medicine and Pathology, University of Minnesota Medical School, Minneapolis 55455, USA.

beta 1-integrins expressed on resting T cells support only minimal adhesion to integrin ligands. T cell activation through multiple stimuli, including phorbol ester treatment and Ab cross-linking of the CD3/TCR complex, results in a rapid and transient switch in integrin function from low to high avidity binding. The exact nature of the intracellular signals involved in this avidity switch remain poorly defined, but the ability of phorbol esters to induce such up-regulation implicates a role for protein kinase C (PKC). We have used a genetic approach to identify factors other than PKC that regulate activation- dependent beta 1-integrin function on T cells. We isolated mutants of the Jurkat T cell line that express beta 1- and beta 2-integrins but do not exhibit increased integrin activity in response to PMA stimulation or CD3 cross-linking. PKC activity appears to be normal in the mutants. One mutation is associated with an altered form of the mitogen- activated protein kinase ERK1 and an inability to produce IL-2. Another mutant with defective integrin function has IL-2 production intact. Complementation analysis verified that these two types of mutants are genetically distinct. Thus, two mutations downstream of PKC have been identified that alter the process of integrin regulation without affecting T cell viability or proliferative capacity. These mutants represent novel reagents for the identification of integrin regulatory factors and indicate possible sites of pharmacologic intervention that could prevent integrin-dependent migration and localization in the process of inflammation, while leaving other T cell functions intact.

This article has been cited by other articles:

				Y. Zaffran, O. Destaing, A. Roux, S. Ory, T. Nheu, P. Jurdic, C. Rabourdin-Combe, and A. L. Astier CD46/CD3 Costimulation Induces Morphological Changes of Human T Cells and Activation of Vav, Rac, and Extracellular Signal-Regulated Kinase Mitogen-Activated Protein Kinase J. Immunol., December 15, 2001; 167(12): 6780 - 6785. [Abstract] [Full Text] [PDF]

				L. K. Cherry, K. S. C. Weber, and L. B. Klickstein A Dominant Jurkat T Cell Mutation That Inhibits LFA-1-Mediated Cell Adhesion Is Associated with Increased Cell Growth J. Immunol., December 1, 2001; 167(11): 6171 - 6179. [Abstract] [Full Text] [PDF]

				E. S. Harris, A. O. Shigeoka, W. Li, R. H. Adams, S. M. Prescott, T. M. McIntyre, G. A. Zimmerman, and D. E. Lorant A novel syndrome of variant leukocyte adhesion deficiency involving defects in adhesion mediated by {beta}1 and {beta}2 integrins Blood, February 1, 2001; 97(3): 767 - 776. [Abstract] [Full Text] [PDF]

				A. FABER-ELMANN, V. GRABOVSKY, M. DAYAN, M. SELA, R. ALON, and E. MOZES An altered peptide ligand inhibits the activities of matrix metalloproteinase-9 and phospholipase C, and inhibits T cell interactions with VCAM-1 induced in vivo by a myasthenogenic T cell epitope FASEB J, January 1, 2001; 15(1): 187 - 194. [Abstract] [Full Text] [PDF]

				V. Grabovsky, S. Feigelson, C. Chen, D. A. Bleijs, A. Peled, G. Cinamon, F. Baleux, F. Arenzana-Seisdedos, T. Lapidot, Y. van Kooyk, et al. Subsecond Induction of {alpha}4 Integrin Clustering by Immobilized Chemokines Stimulates Leukocyte Tethering and Rolling on Endothelial Vascular Cell Adhesion Molecule 1 under Flow Conditions J. Exp. Med., August 14, 2000; 192(4): 495 - 506. [Abstract] [Full Text] [PDF]

				T. B.H. Geijtenbeek, Y. van Kooyk, S. J. van Vliet, M. H. Renes, R. A.P. Raymakers, and C. G. Figdor High Frequency of Adhesion Defects in B-Lineage Acute Lymphoblastic Leukemia Blood, July 15, 1999; 94(2): 754 - 764. [Abstract] [Full Text] [PDF]

				K. S.C. Weber, L. B. Klickstein, and C. Weber Specific Activation of Leukocyte beta 2 Integrins Lymphocyte Function-associated Antigen-1 and Mac-1 by Chemokines Mediated by Distinct Pathways via the alpha  Subunit Cytoplasmic Domains Mol. Biol. Cell, April 1, 1999; 10(4): 861 - 873. [Abstract] [Full Text]

				C. Chen, J. L. Mobley, O. Dwir, F. Shimron, V. Grabovsky, R. R. Lobb, Y. Shimizu, and R. Alon High Affinity Very Late Antigen-4 Subsets Expressed on T Cells Are Mandatory for Spontaneous Adhesion Strengthening But Not for Rolling on VCAM-1 in Shear Flow J. Immunol., January 15, 1999; 162(2): 1084 - 1095. [Abstract] [Full Text] [PDF]

				A. M. O'Rourke, H. Shao, and J. Kaye Cutting Edge: A Role for p21ras/MAP Kinase in TCR-Mediated Activation of LFA-1 J. Immunol., December 1, 1998; 161(11): 5800 - 5803. [Abstract] [Full Text] [PDF]

				N. C. Romzek, E. S. Harris, C. L. Dell, J. Skronek, E. Hasse, P. J. Reynolds, S. W. Hunt III, and Y. Shimizu Use of a beta 1 Integrin-deficient Human T Cell to Identify beta 1 Integrin Cytoplasmic Domain Sequences Critical for Integrin Function Mol. Biol. Cell, October 1, 1998; 9(10): 2715 - 2727. [Abstract] [Full Text]

				E. K. Baker, E. C. Tozer, M. Pfaff, S. J. Shattil, J. C. Loftus, and M. H. Ginsberg A genetic analysis of integrin function: Glanzmann thrombasthenia in vitro PNAS, March 4, 1997; 94(5): 1973 - 1978. [Abstract] [Full Text] [PDF]